Recent guidelines from the European Society of Cardiology have established a threshold of 125 pg/mL NT-proBNP and 100 pg/mL BNP for symptomatic heart failure patients in a non-acute setting; however, the use of this single cut-off value might be suboptimal for screening the general population [31,32,38]. Here, NPPB is linked to heart failure.